Compare ARTW & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTW | NAII |
|---|---|---|
| Founded | 1956 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 15.8M |
| IPO Year | 1996 | 1995 |
| Metric | ARTW | NAII |
|---|---|---|
| Price | $2.48 | $2.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 31.6K |
| Earning Date | 04-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | $22,975,408.00 | ★ $132,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $64.00 | ★ N/A |
| Revenue Growth | N/A | ★ 8.60 |
| 52 Week Low | $2.04 | $2.22 |
| 52 Week High | $4.69 | $4.96 |
| Indicator | ARTW | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 29.46 |
| Support Level | $2.07 | N/A |
| Resistance Level | $2.52 | $2.79 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 16.67 | 12.00 |
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.